LLY compared with ORIC: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

ORICOric Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

ORICOric Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

ORIC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±44.4%▲+27.08%×0.61

Q1 FY26±47.2%▼−0.62%×0.01

= impliedLLY realized, solidORIC realized, hatchedOne scale, both sides: full bar = 48%× = |realized| ÷ impliedSource: market data

Feb 24 '26

±40.3%

▲+14.60%

×0.36

Nov 14 '25±31.1%▲+0.49%×0.02

LLYELI Lilly & Co

1,407.25· pre 1,425.67· delayed

Mkt cap$1.3TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

ORICOric Pharmaceuticals, Inc.

9.57· pre 9.63· delayed

Pre-marketNov 4 '26delayed

Mkt cap$940.1MRevenue—Revenue—

Compare

Pre-marketNov 4 '26delayed

LLYELI Lilly & Co

ORICOric Pharmaceuticals, Inc.

1,407.25pre 1,425.67delayed

Price

9.57pre 9.63delayed

$1.3T

Mkt cap

$940.1M

Q3 FY26$24.4B

Revenue

—

FY25$65.2B

Revenue

—

LLY1,407.25vsORIC9.57Pre-marketNov 4 '26delayed